Products of excellence
Scientific stuff
Publications
Last presentation
Financial reports
Half-year financial report at 06/30/2012
GMP Solutions
MolMed GMP Solutions provides tailor-made services for your cell & gene therapy projects.
Investor kit
MolMed online Investor kit delivers all the financial documents and usefull tools to monitor the share performance. To order printed materials, or request additional investor-related information, complete the Investor contact form.
MolMed S.p.A. is a medical biotechnology company focused on research, development and clinical validation of innovative therapies to treat cancer.
Important stuff
Highlights
Press stuff
Press releases
May 16, 2013
MolMed clinical development update: four studies accepted for presentation at ASCO 2013
May 13, 2013
MolMed Board of Directors approves the interim financial report at 31 March 2013
Subscribe to press releases
Media kit
MolMed online Media kit delivers the information about the company given out to media workers.
Content is constantly updated according to latest press releases and events.
Partnering
MolMed’s business strategy strongly relies on establishing strategic alliances in order to foster the development of its leading products